527 related articles for article (PubMed ID: 27621226)
1. Hemokinin-1 mediates anxiolytic and anti-depressant-like actions in mice.
Borbély É; Hajna Z; Nabi L; Scheich B; Tékus V; László K; Ollmann T; Kormos V; Gaszner B; Karádi Z; Lénárd L; Paige CJ; Quinn JP; Szolcsányi J; Pintér E; Keeble J; Berger A; Helyes Z
Brain Behav Immun; 2017 Jan; 59():219-232. PubMed ID: 27621226
[TBL] [Abstract][Full Text] [Related]
2. Role of tachykinin 1 and 4 gene-derived neuropeptides and the neurokinin 1 receptor in adjuvant-induced chronic arthritis of the mouse.
Borbély E; Hajna Z; Sándor K; Kereskai L; Tóth I; Pintér E; Nagy P; Szolcsányi J; Quinn J; Zimmer A; Stewart J; Paige C; Berger A; Helyes Z
PLoS One; 2013; 8(4):e61684. PubMed ID: 23626716
[TBL] [Abstract][Full Text] [Related]
3. Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms.
Hunyady Á; Hajna Z; Gubányi T; Scheich B; Kemény Á; Gaszner B; Borbély É; Helyes Z
Brain Res Bull; 2019 Apr; 147():165-173. PubMed ID: 30664920
[TBL] [Abstract][Full Text] [Related]
4. Diminished pheromone-induced sexual behavior in neurokinin-1 receptor deficient (TACR1(-/-)) mice.
Berger A; Tran AH; Dida J; Minkin S; Gerard NP; Yeomans J; Paige CJ
Genes Brain Behav; 2012 Jul; 11(5):568-76. PubMed ID: 22471406
[TBL] [Abstract][Full Text] [Related]
5. Hemokinin-1 is a mediator of chronic restraint stress-induced pain.
Borbély É; Kecskés A; Kun J; Kepe E; Fülöp B; Kovács-Rozmer K; Scheich B; Renner É; Palkovits M; Helyes Z
Sci Rep; 2023 Nov; 13(1):20030. PubMed ID: 37973885
[TBL] [Abstract][Full Text] [Related]
6. Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation.
Helyes Z; Elekes K; Sándor K; Szitter I; Kereskai L; Pintér E; Kemény A; Szolcsányi J; McLaughlin L; Vasiliou S; Kipar A; Zimmer A; Hunt SP; Stewart JP; Quinn JP
Neuropeptides; 2010 Oct; 44(5):399-406. PubMed ID: 20579732
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
Scheich B; Gaszner B; Kormos V; László K; Ádori C; Borbély É; Hajna Z; Tékus V; Bölcskei K; Ábrahám I; Pintér E; Szolcsányi J; Helyes Z
Neuropharmacology; 2016 Feb; 101():204-15. PubMed ID: 26387439
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
[TBL] [Abstract][Full Text] [Related]
9. Role of Pituitary Adenylate-Cyclase Activating Polypeptide and Tac1 gene derived tachykinins in sensory, motor and vascular functions under normal and neuropathic conditions.
Botz B; Imreh A; Sándor K; Elekes K; Szolcsányi J; Reglődi D; Quinn JP; Stewart J; Zimmer A; Hashimoto H; Helyes Z
Peptides; 2013 May; 43():105-12. PubMed ID: 23499760
[TBL] [Abstract][Full Text] [Related]
10. Hemokinin-1 is an important mediator of endotoxin-induced acute airway inflammation in the mouse.
Hajna Z; Borbély É; Kemény Á; Botz B; Kereskai L; Szolcsányi J; Pintér E; Paige CJ; Berger A; Helyes Z
Peptides; 2015 Feb; 64():1-7. PubMed ID: 25541043
[TBL] [Abstract][Full Text] [Related]
11. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus.
Patak E; Pinto FM; Story ME; Pintado CO; Fleming A; Page NM; Pennefather JN; Candenas ML
Biol Reprod; 2005 May; 72(5):1125-33. PubMed ID: 15647454
[TBL] [Abstract][Full Text] [Related]
12. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of the tachykinin 4 gene (TAC4-/-) influences the early stages of B lymphocyte development.
Berger A; Benveniste P; Corfe SA; Tran AH; Barbara M; Wakeham A; Mak TW; Iscove NN; Paige CJ
Blood; 2010 Nov; 116(19):3792-801. PubMed ID: 20660792
[TBL] [Abstract][Full Text] [Related]
14. Involvement of tachykinins and NK1 receptor in the joint inflammation with collagen type II-specific monoclonal antibody-induced arthritis in mice.
Makino A; Sakai A; Ito H; Suzuki H
J Nippon Med Sch; 2012; 79(2):129-38. PubMed ID: 22687356
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis and knockout models: NK1 and substance P.
Bilkei-Gorzo A; Zimmer A
Handb Exp Pharmacol; 2005; (169):143-62. PubMed ID: 16594257
[TBL] [Abstract][Full Text] [Related]
16. Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene.
Bilkei-Gorzo A; Racz I; Michel K; Zimmer A
J Neurosci; 2002 Nov; 22(22):10046-52. PubMed ID: 12427862
[TBL] [Abstract][Full Text] [Related]
17. Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice.
Chaves RC; Mallmann ASV; Oliveira NF; Oliveira ICM; Capibaribe VCC; da Silva DMA; Lopes IS; Valentim JT; de Carvalho AMR; Macêdo DS; Vasconcelos SMM; Gutierrez SJC; Barbosa Filho JM; de Sousa FCF
Pharmacol Biochem Behav; 2019 May; 180():44-51. PubMed ID: 30904544
[TBL] [Abstract][Full Text] [Related]
18. Lack of promoter IV-driven BDNF transcription results in depression-like behavior.
Sakata K; Jin L; Jha S
Genes Brain Behav; 2010 Oct; 9(7):712-21. PubMed ID: 20528954
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Neurobehavioral Properties of Naringin in Swiss Mice.
Ben-Azu B; Nwoke EE; Umukoro S; Aderibigbe AO; Ajayi AM; Iwalewa EO
Drug Res (Stuttg); 2018 Aug; 68(8):465-474. PubMed ID: 29529676
[TBL] [Abstract][Full Text] [Related]
20. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.
Duffy RA; Hedrick JA; Randolph G; Morgan CA; Cohen-Williams ME; Vassileva G; Lachowicz JE; Laverty M; Maguire M; Shan LS; Gustafson E; Varty GB
Neuropharmacology; 2003 Aug; 45(2):242-50. PubMed ID: 12842130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
